Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4000 participants
OBSERVATIONAL
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All patients
Continuing with marketed anti-HBV or off-treatment in real-life setting
follow-up
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
follow-up
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients willing to sign the consent to continue anti-viral treatment or post-treatment follow up, and agree his/her legacy data and blood/liver histology samples collected in REALM Study may be used for the analyses planned for this new study.
Exclusion Criteria
2. Patients are formally enrolled into any investigational drug clinical trial after the REALM study.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bristol-Myers Squibb
INDUSTRY
Nanfang Hospital, Southern Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
302 Military Hospital Of China
Beijing, Beijing Municipality, China
Beijing Ditan Hospital
Beijing, Beijing Municipality, China
Beijing Friendship Hospital
Beijing, Beijing Municipality, China
People's Hospital of Beijing University
Beijing, Beijing Municipality, China
The Second Affiliated of ChongQing University of Medical Science
Chongqing, Chongqing Municipality, China
GuangZhou No. 8 People's Hospital
Guangzhou, Guangdong, China
Nanfang Hospital
Guangzhou, Guangdong, China
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Affiliated Hospital of Guiyang Medical College
Guiyang, Guizhou, China
People's hospital of Hainan Province
Haikou, Hainan, China
First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Medical Science Research Institute of Henan Province
Zhengzhou, Henan, China
People's Hospital of Henan Province
Zhengzhou, Henan, China
Tongji Hospital of Huazhong University of Science and Technology
Wuhan, Hubei, China
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
Xiangya Hospital Central South University
Changsha, Hunan, China
No.81 Hospital of PLA
Nanjing, Jiangsu, China
The second hospital of nanjing
Nanjing, Jiangsu, China
Ningbo infectious disease hospital
Ningbo, Jiangsu, China
First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
People's hospital of Jiangsu Province
Suzhou, Jiangsu, China
First Hospital of Jilin Unniversity
Changchun, Jilin, China
No.6 People's hospital of Dalian
Dalian, Liaoning, China
ShengJing Hospital of China Medical University
Shengyang, Liaoning, China
No.6 People's hospital of Shenyang
Shenyang, Liaoning, China
Tangdu Hospital
Xi'an, Shaanxi, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Jinan infectious disease hospital
Jinan, Shandong, China
No.85 Hospital of PLA
Shanghai, Shanghai Municipality, China
Shanghai Ruijin Hospital
Shanghai, Shanghai Municipality, China
First Affiliated Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
West China Hospital of SiChuan University
Chengdu, Sichuan, China
The first affiliated hospital of kunming medical college
Kunming, Yunnan, China
First Affiliated Hospital of Zhejing University
Hangzhou, Zhejiang, China
Hangzhou No.6 people's hospital
Hangzhou, Zhejiang, China
Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, China
First Affiliated Hospital of Beijing University
Beijing, , China
You An Hospital
Beijing, , China
Southwest Hospital Affiliated the Third Military Medical University
Chongqing, , China
Changhai Hospital of the Second Military Medical University of Chinese PLA
Shanghai, , China
Huashan hospital of fudan university
Shanghai, , China
Renji Hospital of Shanghai Jiao Tong University
Shanghai, , China
Shanghai jing 'an district central hospital
Shanghai, , China
Shanghai No.5 People's Hospital
Shanghai, , China
Shanghai Public Health Clinical Center
Shanghai, , China
Zhongshan Hospital of Fudan University
Shanghai, , China
No.3 people's hospital of shenzhen
Shenzhen, , China
Tianjin infectious disease hospital
Tianjin, , China
Tianjin third central hospital
Tianjin, , China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Huafa Yin
Role: primary
Jinghua Hu
Role: primary
Jun Cheng
Role: primary
Hong Ma
Role: primary
Lai Wei, MD
Role: primary
Hong Ren
Role: primary
Min Xu
Role: primary
Jinlin Hou
Role: primary
Dongying Xie
Role: primary
Mingliang Cheng
Role: primary
Feng Lin
Role: primary
Zujiang Yu
Role: primary
Aimin Sun
Role: primary
Jia Shang
Role: primary
Zhengang Zhang
Role: primary
Yongfang Jiang
Role: primary
Deming Tan
Role: primary
Maorong Wang
Role: primary
Wei Zhao
Role: primary
Hao Ying
Role: primary
Jianhe Gan
Role: primary
Donghui Zhou
Role: primary
Junqi Niu
Role: primary
Gongchen Wang
Role: primary
Xiaoguang Dou
Role: primary
Mingxiang Zhang
Role: primary
Jianqi Lian
Role: primary
Shumei Lin
Role: primary
Qiang Li
Role: primary
Chengwei Chen
Role: primary
Qing Xie
Role: primary
Longfeng Zhao
Role: primary
Hong Tang
Role: primary
Wu Li
Role: primary
Qi Xia
Role: primary
Huimin Liu
Role: primary
Huazhong Chen
Role: primary
Xiaoyuan Xu
Role: primary
Zhongping Duan
Role: primary
Jijun Zhou
Role: primary
Chengzhong Li
Role: primary
Wenhong Zhang
Role: primary
Yimin Mao
Role: primary
Hong Wang
Role: primary
Desheng Xie
Role: primary
Jiefei Wang
Role: primary
Shuncai Zhang
Role: primary
Feijian Ao
Role: primary
Yuqiang Mi
Role: primary
Tao Han
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AI463520
Identifier Type: -
Identifier Source: org_study_id